GLIOBLASTOMA MULTIFORME (GBM)
Clinical trials for GLIOBLASTOMA MULTIFORME (GBM) explained in plain language.
Never miss a new study
Get alerted when new GLIOBLASTOMA MULTIFORME (GBM) trials appear
Sign up with your email to follow new studies for GLIOBLASTOMA MULTIFORME (GBM), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New pill targets multiple advanced cancers in early trial
Disease control Recruiting nowThis early-stage trial is testing a new oral drug called KESONOTIDE in people with advanced solid tumors that have spread. The main goal is to find a safe dose and see how well the body handles the medicine. About 80 adults with cancers like prostate, breast, lung, ovarian, and o…
Matched conditions: GLIOBLASTOMA MULTIFORME (GBM)
Phase: PHASE1, PHASE2 • Sponsor: Filamon LTD • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
Helmet uses sound waves to open Brain's barrier for cancer drugs
Disease control Recruiting nowThis early-stage study is testing whether a special helmet that uses focused ultrasound can safely and temporarily open the blood-brain barrier in adults with glioblastoma. The goal is to help standard chemotherapy drugs reach the brain tumor more effectively. Researchers will en…
Matched conditions: GLIOBLASTOMA MULTIFORME (GBM)
Phase: PHASE1 • Sponsor: Sunnybrook Health Sciences Centre • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
New hope for glioblastoma: personalized drug combo enters clinical trial
Disease control Recruiting nowThis trial is testing whether adding a new drug called paxalisib to standard chemotherapy (temozolomide) can better control aggressive brain tumors called glioblastoma. It will enroll about 64 adults whose tumors have specific genetic features. The main goals are to see if the co…
Matched conditions: GLIOBLASTOMA MULTIFORME (GBM)
Phase: PHASE1, PHASE2 • Sponsor: Institute of Cancer Research, United Kingdom • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC
-
New hope for brain cancer patients in groundbreaking UK drug trial
Disease control Recruiting nowThis UK trial is testing new oral drug combinations for aggressive brain tumors like glioblastoma. It aims to see if the drugs avutometinib and defactinib, given alone or with a standard chemotherapy, are safe and can help control tumor growth. The study will enroll 182 patients …
Matched conditions: GLIOBLASTOMA MULTIFORME (GBM)
Phase: PHASE1, PHASE2 • Sponsor: Institute of Cancer Research, United Kingdom • Aim: Disease control
Last updated Mar 03, 2026 14:07 UTC